First US implant of Interventional Spine's RENEW Interspinous Allograft Technology for LSS

Interventional Spine, Inc. today announced the first commercial implant in the United States of its RENEW™ Interspinous Allograft Technology for the Treatment of Lumbar Spinal Stenosis (LSS).

The RENEW™ Implant is an interspinous process device made from allograft for the treatment of lumbar spinal stenosis. Designed for ease of implant and to provide a more "natural" interference within the spinous process, the company believes that this innovative device will improve outcomes and provide cost efficiencies to hospitals and surgeons alike.

The RENEW™ Implant is available in six different sizes to accommodate the patient's anatomy. The Company believes that the market for the RENEW™ Implant exceeds $400 million in the United States and intends to begin a limited product launch of the product in June 2010, with a full U.S. launch by the end of 2010. Interventional Spine believes that the RENEW™ Implant will be a major contributor to revenue growth in 2011 and 2012.

The first implant was performed at the Inova Fairfax Hospital in Fairfax, Virginia by Ronald C. Childs, M.D. Upon completing the procedure, Dr. Childs commented: "I am very pleased with this product. The use of the RENEW™ Implant provides, in my view, a welcomed alternative to the other various interspinous process devices made from synthetic materials presently in the market."

Walter A. Cuevas, Chief Executive Officer of Interventional Spine commented: "The RENEW™ Implant, made from human allograft, has some key patented attributes which make it unique among other interspinous implants. We welcome spine surgeons to visit us in booth 217 at the International Society for the Advancement of Spine Surgery meeting, occurring on April 27 – 30, 2010 in New Orleans, where we will be officially launching the product to the U.S. market."